Shanghai Pharmaceuticals(FRA) S1R

Market Cap€4.56B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€1.22

-0.81%

-0.01Today

Shanghai Pharmaceuticals Financials at a Glance

Market Cap

€4.56B

Revenue (TTM)

€35.50K

Net Income (TTM)

€781.37

EPS (TTM)

€0.16

P/E Ratio

7.72

Dividend

€0.06

Beta (Volatility)

-0.07 (Low)

Dividend

€0.06

Beta (Volatility)

-0.07 (Low)

Price

€1.22

Volume

Open

€1.22

Price

€1.22

Volume

Open

€1.22

Previous Close

€1.22

Daily Range

€1.22 - €1.23

52-Week Range

€1.16 - €1.38

Estimated Earnings Date

N/A

Dividend

€0.06

Beta (Volatility)

-0.07 (Low)

Price

€1.22

Volume

Open

€1.22

Previous Close

€1.22

Daily Range

€1.22 - €1.23

52-Week Range

€1.16 - €1.38

Estimated Earnings Date

N/A

S1R News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shanghai Pharmaceuticals

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

49,608

CEO

Da Wei Liu

Website

www.sphchina.com

S1R Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

6.21%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

12.95%

Dividend Yield

4.85%

Payout Ratio

N/A

Stock Overview

Market Cap

€4.56B

Shares Outstanding

3.71B

Volume

Avg. Volume

72.136

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Shanghai Pharmaceuticals Performance Analysis

Shanghai Pharmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 32,708,688,046	15.8%
2023	2023-12-31	EUR 33,885,896,008	3.6%
2024	2024-12-31	EUR 35,294,591,230	4.2%
2025	2025-12-31	EUR 34,890,585,772	-1.1%

Shanghai Pharmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 0.23	-3.1%
2023	2023-12-31	EUR 0.13	-41.7%
2024	2024-12-31	EUR 0.16	18.8%
2025	2025-12-31	EUR 0.19	20.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€9.12K

+1.1%

Gross Profit

€973.50

+1.1%

Gross Margin

10.67%

+1.0%

Market Cap

€4.56B

N/A

Market Cap/Employee

€0.09

N/A

Employees

49,608

N/A

Net Income

€314.81

+0.8%

EBITDA

€419.18

+1.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€12.99K

+3.4%

Total Debt

€8.50K

+1.0%

Accounts Receivable

€12.06K

+1.1%

Inventory

€5.50K

+1.1%

Long Term Debt

€612.37

+0.8%

Short Term Debt

€7.89K

+1.1%

Return on Assets

1.99%

+0.7%

Return on Invested Capital

6.77%

+0.9%

Free Cash Flow

€652.72

+1.7%

Operating Cash Flow

€699.43

+1.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About S1R

What is the current price of Shanghai Pharmaceuticals?

Shanghai Pharmaceuticals is trading at €1.22 per share.

What is the 52-week range for Shanghai Pharmaceuticals?

Over the past 52 weeks, Shanghai Pharmaceuticals has traded between €1.16 and €1.38.

How much debt does Shanghai Pharmaceuticals have?

As of the most recent reporting period, Shanghai Pharmaceuticals reported total debt of €8.50B.

How much cash does Shanghai Pharmaceuticals have on hand?

Shanghai Pharmaceuticals reported €4.49B in cash and cash equivalents in its most recent financial results.

What is Shanghai Pharmaceuticals’s dividend yield?

Shanghai Pharmaceuticals currently has a dividend yield of 4.85%.

Shanghai Pharmaceuticals(FRA) S1R

Shanghai Pharmaceuticals Financials at a Glance

S1R News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Shanghai Pharmaceuticals

S1R Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Shanghai Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About S1R

What is the current price of Shanghai Pharmaceuticals?

What is the 52-week range for Shanghai Pharmaceuticals?

How much debt does Shanghai Pharmaceuticals have?

How much cash does Shanghai Pharmaceuticals have on hand?

What is Shanghai Pharmaceuticals’s dividend yield?

Premium Investing Services